WuXi AppTec Co., Ltd.
WuXi AppTec is a technology platform offering analytical, process development, clinical research and regulatory services.
Business Model:
Revenue: $5.2B
Employees: 10,001-999,999
Industries / Tags:
Detailed WuXi AppTec Co., Ltd. Information
Geographic Data
Address: 288 Fute Zhong Road
City: Shanghai
State: shanghai municipality
Zip: 200131
Country: CN
Financial Info
Stage:
debt financing
Raised Last:
$2B
Raised Total:$2B
Social
Metrics
735,456Website Global Rank
53,979Website Monthly Traffic
Twitter Followers
Description
WuXi AppTec is a technology platform offering analytical, process development, clinical research and regulatory services.
Contact Phone:
Contact Email:
WuXi AppTec Co., Ltd. went public on 5/8/2018 on the Shanghai Stock Exchange
Listed Exchange:
Shanghai Stock Exchange
IPO Date:
5/8/2018
Ticker Symbol:
2359
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2021 | ShouTi | Series B | 0 |
| 2/2020 | CANbridge Pharmaceuticals | Series D | 98M |
| 8/2018 | Magnolia NeuroSciences | Series A | 0 |
| 3/2019 | Halodoc | Series B | 65M |
| 4/2019 | Arrakis Therapeutics | Series B | 75M |
| 4/2015 | DNAnexus | Series D | 15M |
| 3/2015 | TruTag Technologies | Series B | 0 |
| 7/2018 | Verge Genomics | Series A | 0 |
| 12/2019 | Hui-Gene Therapeutics | Series A | 14.2M |
| 5/2020 | Insitro | Series B | 143M |
| 11/2020 | D3 Bio | Series A | 200M |
| 5/2018 | FogPharma | Series B | 66M |
| 10/2021 | Structure Therapeutics | Series B | 0 |
| 4/2023 | Bioyond Tech | Series A | 0 |
| 3/2020 | Immunocore | Series B | 0 |
| 3/2018 | Hua Medicine | Series D | 0 |
| 1/2019 | Schrödinger | Series E | 0 |
| 10/2018 | Inspirna, Inc.(formerly Rgenix, Inc.) | Series C | 40M |
| 1/2018 | Engine Biosciences | Seed Round | 10M |
| 5/2021 | Engine Biosciences | Series A | 0 |
| 12/2016 | ApoGen Biotechnologies | Series A | 7M |
| 11/2016 | Strateos | Venture Round | 0 |
| 2/2021 | Drug Farm | Private Equity Round | 56M |
| 8/2019 | Huimei Technology | Series C | 30M |
| 11/2017 | AnchorDx | Series B | 28M |
| 5/2017 | CANbridge Pharmaceuticals | Series B | 25M |
| 2/2017 | Forerunner Medical | Series B | - |
| 1/2014 | Avelas Biosciences | Series B | 6.8M |
| 11/2019 | ViGeneron | Series A | - |
| 3/2018 | JW Therapeutics | Series A | 0 |
| 8/2014 | ALDEA Pharmaceuticals | Series B | 24M |
| 1/2020 | Wisdo Health | Series A | 0 |
| 6/2014 | TruTag Technologies | Series A | 0 |
| 6/2021 | Stemirna | Venture Round | 0 |
| 2/2021 | AnchorDx | Series C | 40M |
| 6/2018 | Insilico Medicine | Series A | 6M |
| 5/2021 | MegaRobo | Corporate Round | 0 |
| 6/2020 | JW Therapeutics | Series B | 0 |
| 7/2017 | Rodeo Therapeutics | Series A | 5.9M |
| 10/2016 | UNITY Biotechnology | Series B | 116M |
| 8/2017 | UNITY Biotechnology | Series B | 35M |
| 5/2021 | OakMega | Series A | - |
| 4/2018 | NuProbe | Series A | 11M |
| 10/2021 | ShouTi | Series B | 0 |
| 6/2021 | Stemirna | Venture Round | 0 |
| 5/2021 | MegaRobo | Corporate Round | 0 |
| 5/2021 | Engine Biosciences | Series A | 0 |
| 5/2021 | OakMega | Series A | - |
| 2/2021 | AnchorDx | Series C | 0 |
| 2/2021 | Drug Farm | Series A | 0 |
| 11/2020 | D3 Bio | Series A | 0 |
| 6/2020 | JW Therapeutics | Series B | 0 |
| 5/2020 | Insitro | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2007 | IPO | $184.6M |
|
5/2018 | IPO | $902.6M | 10/2006 | Series B | 1 | - |
Eight Roads Ventures Eight Roads Ventures |
7/2005 | Series A | 1 | $2.2M |
Eight Roads Ventures Eight Roads Ventures |
7/2008 | Post-IPO Equity | 1 | $63M |
Warburg Pincus Warburg Pincus |
3/2016 | Debt Financing | 1 | $1.5B |
Ping An Bank Ping An Bank |
2/2007 | Series C | 1 | $17.3M |
Eight Roads Ventures Eight Roads Ventures Eight Roads Ventures Eight Roads Ventures |
2/2005 | Venture Round | 2 | $11M |
NewSpring Commerce Health Capital NewSpring Commerce Health Capital |
10/2006 | Series B | 1 | - |
Eight Roads Ventures Eight Roads Ventures |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2021 | Oxford Genetics | |
| 5/2019 | Pharmapace | |
| 10/2017 | ResearchPoint Global | |
| 1/2017 | HD Biosciences | |
| 4/2016 | Crelux | |
| 1/2015 | NextCODE Health |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
